Biotechnology Council of New Jersey, Inc.
HomeContact UsLinksSearch

Cord Blood America CEO Matthew Schissler to Appear on New Cancer Awareness Program

LOS ANGELES, June 29 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company which is focused on bringing the life saving potential of stem cells to families nationwide, announced today that CEO Matthew Schissler will appear on the "Your Cancer Today(TM)" show on Thursday, June 29, to discuss the accomplishments in using stem cells in the treatment of certain cancers and the enormous potential of this field.

Your Cancer Today is a new, half-hour broadcast TV show, with an Internet link at http://www.yourcancertoday.com, dedicated to inform and educate viewers on various cancer treatments and the research being conducted. "The program is exploring the vast spectrum of cancer, including diagnosis, treatment and current research breakthroughs, both in the U.S. and abroad, and we are delighted to be featured on one of its very first shows," Mr. Schissler said. "It is vital that people understand the enormous potential of stem cells to launch a new era in medicine, perhaps even curing some of our most intractable diseases, including cancer," Cord Blood America's CEO said.

Those interested in viewing the show should check the listings at http://www.yourcancertoday.com detailing where and when it will appear. The new show already has outlets in many counties in California, including Los Angeles, Orange, Kern, Riverside, San Bernardino and Ventura, and also in Texas and New York.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.cordpartners.com . For investor information, visit www.cordblood-america.com .

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These forward-looking statements including those related to: the potential of stem cells to launch a new era in medicine, curing intractable diseases, including cancer are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB and subsequent Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

    CONTACT:
    Trevor Bryant
    Cord Blood America
    
    

    Paul Knopick
    E & E Communications
    
    

SOURCE Cord Blood America, Inc.